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 
Abstract—Background and Significance: Mechanical alternans 
(MA) is a biomarker associated with mortality and life-threatening 
arrhythmias in heart failure patients. Despite showing prognostic 
value, its use is limited by the requirement of measuring 
continuous blood pressure (BP), which is costly and impractical.  
Objective: To develop and test, for the first time, non-invasive MA 
surrogates based on photoplethysmography (PPG). Methods: 
Continuous BP and PPG were recorded during clinical procedures 
and tests in 35 patients. MA was induced either by ventricular 
pacing (Group A, N=19) or exercise (Group B, N=16). MA was 
categorized as sustained or intermittent if MA episodes were 
observed in at least 20 or between 12 to 20 consecutive beats, 
respectively. Eight features characterizing pulse morphology were 
derived from the PPG and MA surrogates were evaluated.  
Results: Sustained alternans was observed in 9 patients (47%) 
from Group A, whereas intermittent alternans was observed in 13 
patients (68%) from Group A and in 10 patients (63%) from 
Group B. The PPG-based MA surrogate showing the highest 
accuracy, V’M, was based on the maximum of the first derivative 
of the PPG pulse. It detected both sustained and intermittent MA 
with 100% sensitivity and 100% specificity in Group A and 
intermittent MA with 100% sensitivity and 83% specificity in 
Group B. Furthermore, the magnitudes of MA and its PPG-based 
surrogate were linearly correlated (R2=0.83, p<0.001). Conclusion: 
MA can be accurately identified non-invasively through PPG 
analysis. This may have important clinical implications for risk 
stratification and remote monitoring.  
 
Index Terms— Blood pressure (BP), cardiac alternans, 
hemodynamic instabilities, mechanical alternans (MA), 
photoplethysmography (PPG),  
I. INTRODUCTION 
ECHANICAL ALTERNANS (MA; aka blood pressure 
alternans and pulsus alternans) is a condition whereby 
blood pressure oscillates on an every other beat basis showing 
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an alternating sequence of strong-weak-strong-weak beats. The 
first observation of pulsus alternans was in a heart failure 
patient in 1872 [1]. Since then, there has been continuing 
interest in understanding the mechanisms and clinical 
manifestations of this phenomenon [2], [3]. 
Mechanical alternans is an established marker of cardiac 
impairment. Several studies have demonstrated an association 
between MA and heart failure [3]–[5], cardiomyopathy [6]–[8],  
ischemia [2], [9], aortic stenosis [10], [11] and life-threatening 
arrhythmias [2], [12]. The presence of MA has been sufficient 
to identify patients with cardiac risk in heart failure populations 
[3] and MA with sustained pattern with high magnitudes is 
linked to left ventricular disfunction [5]. 
Despite its clear potential as a risk marker, the use of MA is 
seriously limited by the requirement of continuous blood 
pressure monitoring which is done either invasively, for best 
accuracy, or performed through cumbersome and expensive 
non-invasive devices. In contrast to such continuous blood 
pressure (BP) monitoring, photoplethysmography (PPG) based 
devices e.g. pulse oximeters, are non-invasive, cheaper, 
convenient to use and widely available in hospitals and clinics. 
The current expansion of wearable devices allowing continuous 
PPG recordings [13] provides an opportunity for improving  
platforms for remote care monitoring.  
The PPG technology measures hemodynamic changes by 
illuminating arterially perfused tissue with light in the visible 
and infrared spectrum. Arterial pulsations affect the intensity of 
light passing through the tissue, which is captured by a detector 
and forms the PPG waveform. Multiwavelength analysis 
permits the calculation of oxygenated blood in the local tissue, 
an application which today is rarely absent from patient 
monitors. Beyond its conventional use in oxygen saturation 
monitoring, the PPG technology has advanced in recent years 
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and is currently capable of detecting: pulse rate variability, as a 
surrogate of heart rate variability [14], respiratory rate[15], [16] 
sleep apnea [17]–[19], ectopic beats [20], heart rate turbulence 
[21] and atrial fibrillation [22], [23]. Estimation of blood 
pressure is another active area of research, however, achieving 
high accuracy remains challenging [24]–[26], particularly 
without patient-specific calibration. Rather than focusing on 
estimating BP, the aim of this study was to detect specific beat 
to beat blood pressure oscillations. 
We hypothesized that PPG could also be used to detect MA, 
thus providing further insights into patient’s health at low cost 
and new opportunities to improve cardiac risk stratification. 
II. METHODS 
A. Data Sets and Preprocessing  
The study was approved by the local research ethics 
committee and all patients gave informed consent for data 
collection. In total, 39 patients were prospectively recruited. 
Four patients were excluded from the study due to the signal 
being corrupted by either nail polish on the subject’s nail, or 
obstruction of the brachial artery during exercise. The 35 
remaining patients were split in two analysis groups, as shown 
in Table I. 
 
Group A consisted of 19 patients: 12 patients undergoing 
catheter ablation of ventricular tachycardia and 7 patients 
undergoing open heart surgery for coronary artery bypass 
grafting. In the Catheterisation Lab invasive aortic blood 
pressure and PPG, from the finger, were simultaneously 
measured with sampling frequency equal to 240Hz, (Mac-Lab 
System, General Electric), whereas in the cardiac theatre 
invasive aortic blood pressure and PPG were simultaneously 
measured with sampling frequencies equal to 100 Hz, 
(Carescape, General Electric). Ventricular pacing (cycle length 
equal to 505 ± 59 ms, range 410 – 870 ms) was established to 
increase heart rate and induce MA, except in four patients who 
were studied while in incessant monomorphic stable ventricular 
tachycardia. 
Group B consisted of 16 patients undergoing 
cardiopulmonary exercise testing (CPET). During the test, 
patients were positioned on a reclining cycle ergometer and 
exercised from mild to maximum effort. The test followed a 
ramp protocol in which the pedaling workload was set to 0 W 
for the first minute and increased by 10 to 20 W/minute, 
depending on patient fitness. Exercise continued until 
exhaustion or reaching a target heart rate equal to 85% of the 
maximum predicted heart rate (calculated as 220-patient age), 
as per standard protocol. Non-invasive continuous peripheral 
blood pressure was recorded via a finger cuff with a 
FinometerPRO, Finapres Medical Systems. The raw finger 
pressure signal was exported via the device analog output and 
recorded via Matlab through a National Instruments USB-6002 
at a sampling rate of 200Hz. The PPG was recorded from the 
finger with a PO2-100U sensor, iWorx, using an LabScribe 
v2.0; the sampling rate was 200Hz. Both PPG sensors used in 
Group A and B used infrared wavelengths to sense tissue 
volume variations. The peak wavelength was 940nm for Group 
A and 910nm for group B. Overall, the average recording time 
was 16m 26s (±12m 15s). For Group A it was 19m 31s (±15m 
23s), and for Group B it was 12m 47s (±5m 28s). 
A finite impulse response (FIR) low pass filter with a 30Hz 
cut-off frequency was used to reduce noise in the PPG signals 
as well as in the BP signals recorded invasively through an 
arterial line (Group A). To reduce noise in the BP recordings 
provided by the non-invasive finger probe (Group B) a lower 
cut-off frequency of 10 Hz was required. The filter order was 
adjusted to the signal sampling frequency as half its value.  
An automated peak selection algorithm was employed to 
detect each PPG pulse and its corresponding BP pulse. The 
algorithm evaluates the signal derivative, selects peak values 
over a threshold and excludes peaks which are less than 
200ms apart. Depending on the measurement location, PPG 
peaks follow BP peaks by an approximate time delay. We 
used a time window for this delay, to assess the accuracy of 
the PPG peaks allocation. Furthermore, to exclude bigeminy 
and ectopic induced oscillations from the MA analysis, beats 
accompanied by changes in cycle length of more than 200ms 
were excluded. 
B. General Definition and Detection of Alternans 
Let us define a time series {𝑋𝑛}𝑛=1
𝑁  representing a sequence 
of values for a given pulse-specific feature extracted from either 
the BP or PPG signal; n is the beat number and 𝑁 is the total 
number of beats. An alternating sequence of 𝑄 beats was 
identified by an uninterrupted succession of beats, showing an 
alternating pattern (high-low-high-low), satisfying: 
{
(𝑋𝑛 > 𝑋𝑛−1 𝐴𝑁𝐷 𝑋𝑛 > 𝑋𝑛+1) 𝑂𝑅 




      (1) 
where 𝑄𝑖  and 𝑄𝑓 are the initial and final beat numbers of the 
alternating sequence, and 𝑄 = 𝑄𝑓 − 𝑄𝑖 + 1. 
Based on the value of 𝑄, we categorized alternans episodes 
as Sustained, if the alternating pattern was uninterrupted for at 
least 20 consecutive beats (𝑄 ≥ 20), and as Intermittent if the 
alternating pattern was uninterrupted for at least 12, but no more 
than 19, consecutive beats (12 ≤ 𝑄 < 20). 
Furthermore, the magnitude of the alternans episode was 
measured as: 







𝑛=𝑄𝑖       (2) 
where ∆𝑋𝑛 = 𝑋𝑛 − 𝑋𝑛−1 , and 𝑄𝑖  and 𝑄𝑓 are the initial and final 
beat numbers of the alternans episode. 
TABLE I 
Data Collection Groups 
 Group A Group B 
Patients 7 12 16 
Setting  Cardiac Theatre Catheter Lab Outpatient Care 
Intervention Cardiac Surgery Catheter Ablation CPET 












GE: General Electric; CPET: Cardiopulmonary exercise test. 
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C. Definition of Mechanical Alternans  
As shown in Fig. 1, mechanical alternans was detected based 
on the dynamics of the maximum of the first derivative of the 
BP signal: 
𝑋𝑛 =  𝑃𝑀
′ (𝑛) = 𝑚𝑎𝑥𝑡∈𝐼𝑃𝐼 (
𝑑𝑃(𝑡)
𝑑𝑡
)      (3) 
where 𝐼𝑃𝐼  is the time interval within the 𝑛




A MA episode was classified as: 
 Sustained MA (Fig. 2a) if the magnitude of the alternans 
episode was higher than 4% and the alternating pattern 
was uninterrupted for at least 20 consecutive beats 
(∆𝑟𝑃𝑀
′̅̅ ̅̅ ̅̅ ̅ > 4% and 𝑄 ≥ 20); 
 Intermittent MA (Fig. 2b) if the magnitude of the alternans 
episode was higher than 4% and the alternating pattern 
was uninterrupted for at least 12, but no more than 19, 
consecutive beats (∆𝑟𝑃𝑀
′̅̅ ̅̅ ̅̅ ̅ > 4% and 12 ≤ 𝑄 < 20). 
Results obtained using different values for Q and ∆𝑟𝑃𝑀
′  are 
presented in the supplementary Table S.I. 
Patients that exhibited at least one episode of alternans were 
classified as sustained MA positive (𝑀𝐴𝑆
+) or intermittent MA 
positive (𝑀𝐴𝐼
+), depending on the MA duration. Patients not 
showing MA were classified as MA negative (𝑀𝐴−). 
D. Feature Extraction and PPG-Based MA Surrogates  
Eight pulse-specific indices were defined and measured for 
each PPG pulse. Seven of these features are illustrated in Fig. 3 
for a single PPG pulse, the 8th being the pulse mean over the 
pulse interval. Beat-to-beat oscillations in these eight indices 
were then analyzed as previously described in section B. 
Sustained and intermittent MA was detected based on the 
number of consecutive beats showing an uninterrupted 
alternating sequence and the alternans magnitude ∆𝑟𝑋̅̅ ̅̅ ̅ > ∆𝑋0, 
where ∆𝑋0 is an optimal threshold maximizing accuracy 
detection estimated by receiver operating characteristic (ROC) 
analysis, which was performed by incrementally varying the 
threshold value from 0% to 60%. 
 
 
Fig. 1.  Method of calculating alternans magnitude. Recording showcasing 
sustained alternans present in systolic BP, in the first derivative of BP, P’, 
and the absolute magnitude calculated as the difference between two 
consecutive strong and weak peaks of P’.  
 
Fig. 2.  Recordings showing sustained (a) and intermittent (b) alternans in both BP and PPG.  Columns from left to right show the signal (BP in mmHg), 
its derivative (P’ in mmHg/s) and the beat to beat changes in the first derivative peaks (ΔP’M in mmHg/s). PPG (V), V’ and ΔV’M are shown in arbitrary 
units . In the third column, black circles indicate the duration of mechanical alternans.   
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Patients exhibiting at least one MA episode in the PPG were 
classified as true or false positive, based on the presence of 
MA in the BP. Similarly, patients that did not exhibit MA in 
PPG features were classified as true or false negative based on 
the absence of MA in the BP. Sensitivity and specificity were 
calculated as the true positive rate and true negative rate, 
respectively. The range of the best performing threshold 
values are presented in Table II and III. 
III. RESULTS 
Out of 35 patients, 23 showed intermittent BP MA (13 in 
Group A and 10 in Group B), 9 of which also exhibited 
sustained BP MA (all in Group A). The average peak detection 
accuracy in the PPG recordings was 98.1 % (±3.93%); for 
Group A, 98.1% (±3.37%), and for Group B, 98.2% (±4.63%). 
Tables II and III summarize the performance of PPG-based 
surrogates for MA, for sustained and intermittent MA 
respectively. Sensitivity, specificity and accuracy relative to the 
thresholds identified by ROC analysis are shown along with 






Fig. 3.  Definition of PPG indices used in the study. Left: A single PPG pulse. The y-axis represents the magnitude of the signals arbitrary units. Eight pulse 

















V’M (0-10) 100 100 100 0.95 
A (0-16) 100 100 100 0.92 
a (23-29) 100 90 95 0.82 
VM (0-8) 89 100 95 0.66 
IPI (0-3) 89 90 89 0.93 
?̅? (0-8) 78 100 89 0.49 
IPW (22-23) 78 100 89 0.81 
ICT (0-7) 78 100 89 0.62 
Group A – Ventricular Pacing/Tachycardia Induced MA; 9 patients 





































V’M (0-20) 100 100 100 0.94 (6-8) 100 83 94 0.41 (6-8) 100 92 97 0.91 
IPW (0-23) 100 67 89 0.61 (0-7) 100 67 88 0.35 (0-7) 100 67 89 0.66 
IPI (0-1) 100 83 95 0.90 (0-1) 70 83 75 0.08 (0-1) 87 83 86 0.81 
A (18-21) 100 100 100 0.91 (8-10) 80 83 81 0.47 (18-21) 78 100 86 0.82 
VM (0-5) 92 83 89 0.20 (0-1) 100 50 81 0.76 (0-1) 96 67 86 0.15 
a (0-40) 100 100 100 0.87 (24-26) 70 50 63 0.06 (40) 74 92 80 0.70 
ICT (8) 77 83 79 0.73 (0-8) 70 67 69 0.07 (8) 74 75 74 0.64 
?̅? (0-3) 85 67 79 0.48 (14-15) 60 67 63 -0.01 (0-3) 78 58 71 0.46 




ROC curves for the top 5 performing indices are shown in 
Fig. 4. Based on the area under the curve, V’M, was the best 
surrogate for MA detection, providing 100% sensitivity and 
100% specificity in Group A for both sustained and intermittent 
alternans, and 100% sensitivity and 83% specificity in Group B 
for intermittent MA. For intermittent MA defined by different 
thresholds and window lengths, the results are similar. They are 




Indices based on pulse morphology, such as pulse amplitude 
(A and VM) and area (a) also performed well, with accuracy 
>85% for both sustained and intermittent (group A+B) 
alternans. Interestingly, pulse interval also provided good 
accuracy in the detection of MA, possibly as it is affected by 
ventricular contractility. Patients with sustained alternans were 
detected with high accuracy (>89%) by all the PPG indices. 
Intermittent alternans was detected with greater accuracy in 
Group A than in Group B.  
The correlation between the magnitude of MA and the 
magnitude of PPG-based MA was high, and greater in Group A 
than B (Tables II and III). 
Index V’M outperformed the other indices, showing a Pearson 
correlation equal to 0.94, 0.41 and 0.91 for Groups A, B and 
A+B respectively. A scatter plot of the relative magnitudes of 
alternans in V’M in each patient is presented in Fig. 5. Patients 
that exhibited alternans only in the PPG were included in the 
correlation analysis and were considered to have zero 
magnitude of alternans in BP. 
Among the 23 alternans positive patients, 258 episodes of 
MA (both intermittent and sustained) were detected in the blood 
pressure and 273 episodes were detected in the PPG. 
In Group B, where heart rate varied due to exercise it was 
possible to study the interaction between occurrence of MA and 
heart rate. Here, there were 25 episodes of (intermittent) MA in 
BP and 26 episodes of MA in the PPG (V’M).  
The magnitude spread of these episodes and the occurrence 
within normalized heart rate intervals is illustrated in Fig. 6. 
Normalization was done with respect to the predicted maximum 
heart rate of each patient. The results are very similar between 
BP and V’M. The relative magnitude of alternans was higher for 
V’M closer to the maximum predicted heart rate, however the 
frequency of episodes within the heart rate intervals was akin to 
episodes of MA in BP. 
 
 
Fig. 4.  Mechanical Alternans categorization performance for the top 5 PPG indices. There are 23 patients with intermittent alternans in BP and 12 without. 
ROC curves are constructed by varying the alternans relative magnitude threshold between 0 and 60%.  
 
Fig. 5.  Magnitude correlation for MA in BP and PPG V’M. Each point 
represents a patient with either sustained or intermittent alternans. The 
coordinates represent the mean relative magnitude of all the alternans 
episodes detected in a patient. The line fitting was done for all the patients, 
R = 0.904. For patients with intermittent and sustained MA, the correlations 




This study demonstrates for the first time that patients with 
MA can be accurately identified using the PPG signals alone 
and may have important implications in facilitating risk 
stratification in heart failure. Although PPG oscillations have 
been previously reported anecdotally during MA [27], [28], to 
the extent of our knowledge, this is the first quantitative 
investigation of PPG-based surrogates for MA. 
Two groups of patients were investigated: Group A, where 
BP was measured invasively and Group B where it was 
measured non-invasively. Furthermore, in Group A, MA was 
induced either by pacing or by sustained stable VT, whereas in 
Group B, MA was induced by exercise, through CPET. 
Sustained alternans was solely present in Group A, possibly 
because patients undergoing catheter ablation for ventricular 
tachycardia or cardiac surgery for coronary artery bypass 
grafting had poorer ventricular function than patients in group 
B and because ventricular pacing/tachycardia is known to 
facilitate the establishment of MA [6]. Detection of MA was 
more challenging in Group B than in Group A not only because 
exercise less effective than ventricular pacing/tachycardia in 
inducing MA and patients had better ventricular function, but 
also because the reference signal for MA in this group, i.e. 
blood pressure, was measured non-invasively and 
measurements were more prone to movement artefacts due to 
exercise. As expected, all PPG indices performed better in 
Group A than in Group B.  
Alternans was categorized as sustained or intermittent. 
Sustained alternans has been more widely investigated [2]–[8], 
[12] and its prognostic value has been demonstrated in several 
studies [3], [6], [8]. We also considered intermittent MA, which 
occurs sporadically in short episodes and often shows lower 
magnitude, because we hypothesized that this may be useful as 
an earlier predictor of adverse cardiovascular outcome. Further 
investigation is needed to assess the prognostic value of both 
sustained and intermittent PPG-derived MA.   
The PPG first derivative pulse peak, V’M, was the best 
surrogate for MA, with 100% sensitivity and 92% specificity 
for intermittent MA in group A+B. In Group A, both sustained 
and intermittent MA were detected with 100% sensitivity and 
100% specificity using both the maximum of the pulse 
derivative (V’M) and pulse amplitude (A).  
The magnitude of MA was highly correlated between BP and 
PPG indices V’M, pulse interval and pulse amplitude (Tables III-
IV). The correlation was higher for patients with sustained 
alternans (Fig. 5). The lower correlation of intermittent 
alternans can be explained by the low MA magnitude values 
(<35%) for both BP and PPG. In Group B, the correlation was 
also lower for most indices, possibly on account of movement 
artifacts related to exercise and apparatus limitations in 
detecting BP non-invasively [29].  
In Table III we presented the best performing threshold 
values for each group individually, as well as for group A and 
B combined. In Group A, accuracy can be maximized using a 
wide range of thresholds, while in Group B accuracy is 
maximized using similar thresholds but within a narrower 
window, since the magnitude of mechanical alternans was 
generally lower in this group. 
The PPG pulse interval index was a good surrogate for MA, 
detecting sustained and intermittent MA with 95% and 86% 
accuracy, respectively. Interesting, small pulse interval 
variations allowed to accurately detect MA even when the heart 
rate was fixed (Group A). Similar variations have been reported 
before in pulse arrival time during pacing [30]. Since pulsations 
of higher pressure travel faster through arteries [31], we 
hypothesize that this may be due to beat-to-beat variations in 
contractility directly translating into variations in the pulse 
arrival time and therefore in the pulse interval.  
Fig. 6 shows a qualitative trend of MA magnitude 
dependence on heart rate – very similar to what is present in [7], 
where MA generated through atrial pacing also shows a heart 
rate dependent peak magnitude. We believe this is an area that 
needs to be further examined, as literature provides little 
information on this. 
Our hypothesis was that PPG could be used to track 
oscillations in the blood pressure, and therefore MA could be 
detected via PPG regardless of the underlying mechanisms, due 
to the intrinsic link between blood pressure and arterial flow 
[32]. Previous studies have shown that MA can be observed in 
both ventricular blood pressure [12] and in the aortic ejection, 
via Doppler measurements [33]. MA has also been detected in 
the peripheral arterial blood pressure [8], with significant 
increase in magnitude compared to left ventricle alternans. Due 
to peripheral blood pressure augmentation [34] and the PPG’s 
ability to detect changes in peripheral blood flow [35], it was 
assumed that alternans could be optically detected at peripheral 
sites, i.e. finger, wrist. 
 
Fig. 6.  Interactions between heart rate and magnitude of alternans episodes 
in BP and PPG V’M. The number of alternans events within each heart rate 
interval is presented under each group. Statistically significant differences 
were calculated using the Mann-Whitney U ranked test. 
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While this study demonstrates that the PPG is a technology 
that can track beat to beat blood pressure oscillations, its use for 
accurate cuffless blood pressure estimation remains a 
challenging task [24]–[26]. 
A. Definition of Mechanical Alternans 
The definitions of MA have varied slightly in literature, 
however there seems to be a consensus that MA indicates 
poorer prognosis when it is sustained and has higher magnitude. 
Sustained alternans has often been defined as a systolic or dP/dt 
alteration over 20 beats or more. A threshold is commonly 
employed to discard low magnitude alternans, i.e. 4mmHg [3] 
for systolic BP, 100mmHg/s [7] for max dP/dt, particularly in 
clinical studies. However, there are also studies looking at 
microsystolic blood pressure alternans (MBPA) [8] which 
consider alternans of all magnitudes.  
In this study, the definition of sustained alternans was 
maintained as 20 alternating beats or more, and an adaptive 
threshold was introduced, 4% relative change to the stronger 
beat. In our study population, a 4% change in peak dP/dt, P’M, 
corresponds to 33 (± 24 mmHg/s).  
Intermittent alternans were defined as 12 consecutive beats 
or more to avoid evaluating unwanted short variations. It has 
been shown that similar variations [36], which we wanted to 
exclude from our analysis, can occur from ectopic beats and last 
for up to 8-10 beats. 12 was chosen to allow us to evaluate the 
shortest MA episodes while also excluding unwanted 
variations. 
Mechanical alternans could also be defined in terms of a 
spectral power index, if the spectral method is used for 
detection. However, the spectral method is limited in assessing 
intermittent alternans, and its sensitivity is susceptible to 
ectopics and noise [37]. 
B. Clinical Perspective 
PPG-derived MA may represent a novel useful prognostic 
marker in patients with heart failure. The ability to detect MA 
with existing, widely available medical equipment, opens 
avenues for further clinical investigations into its prognostic 
utility to risk stratify patients who may benefit from an 
implantable cardioverter defibrillator or ventricular assist 
device. With the expansion of wearable devices and m-health, 
one could speculate that MA could be integrated into an 
adaptive multi-variate risk-prediction model based on data 
recorded through a PPG sensor continuously monitoring heart 
rate, heart rate variability [14], turbulence [21] and respiratory 
rate [15], [16]. The combination of predictors related to 
complementary pathophysiological mechanisms provides 
better risk profiling [38] and an opportunity that should be 
tested in future studies.  
C. Limitations and Future Studies 
Studies with longer recording times are needed to assess the 
accuracy during long term monitoring. In our cohort the 
average recording time was 16m 26s (±12m 15s) and it was 
limited by the procedure or patient fitness. 
The continuity required for our analysis was affected, in 
Group B, by frequent recalibrations of the Finometer. 
Movement artifacts affect both the PPG and noninvasive BP. 
Although noise reduction in the PPG is an active field of study, 
sophisticated techniques of signal reconstruction during 
movement have focused on accurate estimations of heart rate 
[39], [40]. PPG motion artifact reduction remains a challenging 
task. In this study, PPG has been recorded in stable, and mild 
movement conditions, as per clinical procedure. 
The presence of alternans was investigated independently in 
each PPG pulse feature, in order to find a direct surrogate for 
MA that is easy to measure and implement. Although the results 
in our cohort have been satisfactory for several PPG features, a 
multi-variable analysis and machine learning techniques could 
be used to further improve the ability of PPG to detect alternans. 
These are more likely to be needed in challenging recording 
settings, such as wearable wrist devices, where movement 
artifacts are frequent and skin perfusion is low. This 
optimization could enable more widespread use of PPG data 
both in the hospital setting and for home monitoring to enable 
treatment and risk stratification in community care. 
V. CONCLUSION 
This study demonstrates that blood pressure mechanical 
alternans, an independent marker of cardiovascular impairment 
and predictor of poor outcome in heart failure patients, can be 
detected using PPG-based surrogates. This novel methodology 
opens new possibilities for improving risk stratification of 
cardiac patients, but future studies are needed to determine its 
clinical implications and impact. 
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